About

Founded

2007

Headquarters

Yoqne`am `illit, HaZafon, Israel

Industry

Healthcare

Company Description

Vibrant® is an FDA-cleared, drug-free, state-of-the-art treatment that uses micro-vibrations to help your bowels work more normally. Vibrant® provides a new and unique way to solve an old problem.

Quick Links

Website Jobs

Funding

Total Raised

$15 million

Valuation

Undisclosed

Significant Investors

Sequoia Capital, Unorthodox Ventures

Company Traction

Vibrant received FDA marketing authorization on August 2022.

Only 1.2% of diarrhea occurrence was demonstrated in Vibrant’s clinical trials.

‍

Leadership Team

Lior Ben-Tsur: CEO at Vibrant. Former VP of Marketing & Sales at FriCSo.

Ben Feldman: CMO at Vibrant. Former CMO at AposHealth.

Catherine Miller Collis: Chief Commercial Officer at Vibrant. Former VP of US Sales & Marketing at Zealand Pharma.

Martha Bezalel: COO at Vibrant.‍

Uri Neria: Head of Product at Vibrant. Former Head of LiveScreen Product & Business Unit at Celltick.

Press

Vibrant Blog (August 30, 2022): FDA grants marketing authorization for Vibrant®, a new first-in-class, drug-free treatment for adults with chronic idiopathic constipation

TechCrunch (March 26, 2021): Vibrant raises $7.5M for a drug-free mechanical pill to treat constipation

Vibrant